Amgen Inc (AMGN)
305.87 -0.99 (-0.32%) 14:47 ET [NASDAQ]
305.85 x 18 306.03 x 20
Realtime by (Cboe BZX)
305.85 x 18 306.03 x 20
Realtime 306.06 -0.80 (-0.26%) 09:28 ET
for Wed, Mar 26th, 2025
Results
download Want to compare other data? Select Fields| Symbol | AMGN | AZN | GILD | ||
| Company | Amgen Inc | Astrazeneca Plc ADR | Gilead Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 306.44 | 72.38 | 107.99 | ||
| High | 309.09 | 73.11 | 110.46 | ||
| Low | 304.35 | 71.82 | 107.90 | ||
| Last | 306.03 | 73.04 | 109.65 | ||
| Change | -0.83 | -0.01 | +1.76 | ||
| % Change | -0.27% | -0.01% | +1.63% | ||
| Volume | 886,148 | 4,490,588 | 3,924,106 | ||
| 20-Day Average Volume | 3,113,790 | 5,812,962 | 10,772,897 | ||
| Previous Close | 306.86 | 73.05 | 107.89 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 314.57 | 76.02 | 112.19 | ||
| 20-Day Raw Stochastic | 9.82% | 19.05% | 34.24% | ||
| 20-Day Relative Strength | 50.65% | 46.04% | 55.34% | ||
| Weighted Alpha | +6.41 | +4.43 | +57.84 | ||
| Today's Opinion | 16% Buy | 24% Sell | 80% Buy | ||
| Previous Opinion | 32% Buy | 8% Sell | 80% Buy | ||
| Last Month's Opinion | 24% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.99% since 03/19/25 | -4.26% since 03/19/25 | +2.25% since 03/19/25 | ||
| Low | 303.51 on 03/25/25 | 71.82 on 03/26/25 | 104.70 on 03/20/25 | ||
| High | 317.58 on 03/24/25 | 77.01 on 03/20/25 | 110.46 on 03/26/25 | ||
| 1-Month | |||||
| %Chg | -0.02% since 02/26/25 | -3.25% since 02/26/25 | -0.48% since 02/26/25 | ||
| Low | 303.10 on 02/27/25 | 71.82 on 03/26/25 | 104.70 on 03/20/25 | ||
| High | 335.88 on 03/10/25 | 78.36 on 03/05/25 | 119.96 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | +16.39% since 12/26/24 | +9.84% since 12/26/24 | +16.43% since 12/26/24 | ||
| Low | 257.05 on 01/06/25 | 64.22 on 01/14/25 | 88.57 on 01/10/25 | ||
| High | 335.88 on 03/10/25 | 78.36 on 03/05/25 | 119.96 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | -4.01% since 09/26/24 | -6.54% since 09/26/24 | +32.38% since 09/26/24 | ||
| Low | 253.30 on 12/19/24 | 62.75 on 11/18/24 | 82.82 on 10/01/24 | ||
| High | 335.88 on 03/10/25 | 79.76 on 10/02/24 | 119.96 on 03/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 164,846,720 | 226,543,696 | 134,360,368 | ||
| Shares Outstanding, K | 537,205 | 3,101,214 | 1,245,346 | ||
| Annual Sales | 33,424,000,000 | 54,073,000,000 | 28,754,000,000 | ||
| Annual Net Income | 4,090,000,000 | 7,035,000,000 | 480,000,000 | ||
| Last Quarter Sales | 9,086,000,000 | 14,891,000,000 | 7,569,000,000 | ||
| Last Quarter Net Income | 627,000,000 | 1,499,000,000 | 1,783,000,000 | ||
| 60-Month Beta | 0.53 | 0.41 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.31 on 02/04/25 | 1.05 on 02/06/25 | 1.90 on 02/11/25 | ||
| Latest Earnings Date | 05/01/25 | 04/24/25 | 04/24/25 | ||
| Most Recent Dividend | 2.380 on 02/14/25 | 1.030 on 02/21/25 | 0.790 on 03/14/25 | ||
| Next Ex-Dividends Date | 05/16/25 | 02/21/25 | 03/14/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 15.86 | 18.03 | 23.15 | ||